Cancer Research UK-funded researchers have developed a new technique to help experts diagnose Barrett’s esophagus—a pre-cancerous condition that can increase the risk of developing oesophageal cancer. Published today in Nature Medicine, the study explored how artificial intelligence could help free up pathologists time and allow them to focus on diagnosing the trickiest cases of Barrett’s
High-risk prostate cancer, that which has continued to grow but not yet metastasized, is commonly treated with combination therapies. Each method has pros and cons, but there is little clarity whether one might be more effective than the other. For the first time, researchers have shown that more patients live longer if treated with the
Adding the monoclonal antibody drug trastuzumab—already used to treat certain breast cancers—to the chemotherapy regimen of women with a rare form of uterine cancer lengthens the amount of time their tumors are kept from growing, according to Johns Hopkins Medicine researchers conducting a small phase II trial of the regimen, testing its safety and value.
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok